首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 藥品產業合作管理
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

藥品產業合作管理

Pharmaceutical Alliance Management

出版商 Cutting Edge Information
出版日期 2008年09月 商品編碼 71498
內容資訊 英文 86 Pages
價格
US $ 4995 PDF by E-mail (Single User License)
US $ 16995 PDF by E-mail (Multi User License)


藥品產業合作管理 是由出版商Cutting Edge Information在2008年09月所出版的。 這份英文市場調查報告書包含86 Pages 價格從美金4995起跳。

簡介

本報告書內容包括:建立藥品產業穩固合作關係的策略、決定問題與解決、合作對象選擇動向等。內容綱要摘記如下:

實施概要

  • 調查對象企業
  • 調查方法・定義
  • 商業開發:成功的5大原則

合作管理

  • 正式的合作管理集團

合作的健全性及紛爭解決

  • 紛爭解決

計畫管理的調整

為了成為被選擇的合作對象

封面圖片:
表紙

目錄

Abstract

Drive revenue through alliance success:

Nearly half of today' s top-selling drugs were the result of partnerships. Companies across the industry annually spend hundreds of millions of dollars to utilize other firms' discovery, development and marketing capabilities in their quests for the next blockbusters.

This pressure to maintain strong portfolios underscores the importance of alliance management. Alliance management is a crucial step in the deal-making process. But it is here that many deals fall apart. At this stage, the burden rests on alliance management personnel to keep things running smoothly. Ensuring a thriving collaboration is a daunting responsibility requiring many parts - ample organizational support, efficient project coordination, and constant, open communication.

Companies that excel in alliance management position themselves to win new deals. Those organizations that show a penchant for successful collaborations will attract other companies looking for strong allies - in the process filling critical portfolio holes and penetrating exciting new markets.

Pharmaceutical Alliance Management focuses on overcoming post-deal management challenges. Findings and interviews with pharma and biotech industry leaders provide proven, successful approaches for partnership success. The report instructs alliance managers on how to:

  • Develop a robust alliance management strategy
  • Gain key stakeholders' support and organizational resources
  • Cultivate deeply rooted partner relationships
  • Identify and eliminate problem areas
  • Monitor alliance health
  • Attain partner-of-choice status

Table of Contents

Sample Content

The following excerpt is taken from Chapter 1: Alliance Management. The full report examines deal maintenance and satisfaction in detail.

Signaling Internal Commitment to Partner Asset

The single most important factor in maintaining partner satisfaction in any alliance, according to surveyed companies, is valuing the collaborative asset as much as internally developed products and technologies. Companies with reputations as partners of choice communicate their equivalent valuation in soft measures to partners and in hard measures to the rest of the world.

Pharmaceutical companies conduct partnerships to reach beyond what they can do for themselves; treating partners and their assets with respect follows directly from this strategic decision.

Company P' s alliance managers are building a culture that treats alliances as strong strategy components rather than business sidelines. This strategy involves the following points:

  • Build the Culture - The alliance department or group must start building a culture in which partner products are treated as well as the company' s own. Company representatives must be trustworthy and straightforward in dealing with partners
  • Encourage Respectful Behavior - Alliance managers set the relationship' s tone and ensure that other alliance team members adhere to it by treating partners as equals, attending key meetings, keeping commitments, and meeting deadlines.
  • Communicate About Partner Internally - Company P' s alliance managers construct a cohesive model of the partner' s business and present it to every internal team that deals with the alliance, including senior management. These presentations include information on the partner' s business model, key issues, pipeline.....

The following excerpt is taken from Chapter 2, Alliance Health and Conflict Resolution.

Alliance Health Surveys

The most common measurement tool is the alliance health survey, which is administered at standard times during an alliance' s lifecycle. Alliance health surveys aid companies in measuring the true progression of collaborative efforts and, more importantly, in determining how internal and external stakeholders view their alliances. The survey results also accomplish the following:

  • Ensure that both companies are on the same page regarding standards, milestones and strategy
  • Provide analysis of the effectiveness of the communication between the two companies
  • Quantify the level of trust each company has for the other
  • Coordinate strategy to either maintain the current good relations or to bring the alliance up to that level.

The survey may take significant effort to create, but once created, it only needs to be slightly adjusted for future deals. For teams seeking outside help, alliance management vendors supply survey templates and customized support.

Many companies, however, neglect to establish even this most popular and simple method of measuring an alliance' s health. As seen in Figure 2.1 [Data figures appear in full report], only 31% of surveyed companies actually make use of alliance health surveys. This is because formal alliance health measurements are generally a product of formal alliance management departments (see Figure 2.2).

Back to Top